Presentation TCT 2025 Position 2: DCB/Hybrid Treatment Presenter: Antonio Colombo October 26, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 Updates from the Clear-IE Registry-Special Subgroups Presenter: Abdallah El Sabbagh October 26, 2025 More slides + Presentation TCT 2025 Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial Presenter: Ulf Teichgräber October 26, 2025 Presentation TCT 2025 INCORPORATE-EXTENDED: Two-Center Long-Term Outcomes of an Intentional Invasive vs Conservative Coronary Strategy After Critical Limb Ischemia Revascularization Presenter: Sadeek Sidney Kanoun Schnur October 26, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 Updates from the Clear-IE Registry-Special Subgroups Presenter: Abdallah El Sabbagh October 26, 2025
Presentation TCT 2025 Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial Presenter: Ulf Teichgräber October 26, 2025
Presentation TCT 2025 INCORPORATE-EXTENDED: Two-Center Long-Term Outcomes of an Intentional Invasive vs Conservative Coronary Strategy After Critical Limb Ischemia Revascularization Presenter: Sadeek Sidney Kanoun Schnur October 26, 2025